HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,910: | Line 1,910: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || | |IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || | |Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG | |Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG | ||
| || | | || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG | |Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG | ||
| || | | || | ||
| | |Primary Amyloidosis | ||
|Heather E. Williams, PhD, MS, PgD, ErCLG | |Heather E. Williams, PhD, MS, PgD, ErCLG | ||
| | |?PENDING<br /> | ||
| | | | ||
| | | | ||
| Line 1,948: | Line 1,948: | ||
|Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG | |Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG | ||
| || | | || | ||
| | |Light Chain and Heavy Chain Deposition Disease | ||
|Chen Yang, MD, PhD, University of Michigan | |Chen Yang, MD, PhD, University of Michigan | ||
| | |Complete | ||
| | |10/15/2022 | ||
| | | | ||
|- | |- | ||
|Mu heavy chain disease||Disease|| || || || || ||SG | |Mu heavy chain disease||Disease|| || || || || ||SG | ||
| || | | || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Gamma heavy chain disease||Disease|| || || || || ||SG | |Gamma heavy chain disease||Disease|| || || || || ||SG | ||
| || | | || | ||
| | |Gamma Heavy Chain Disease | ||
|Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | |Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | ||
| | |Complete | ||
| | |5/26/2021 | ||
| | | | ||
|- | |- | ||
|Alpha heavy chain disease||Disease|| || || || || ||SG | |Alpha heavy chain disease||Disease|| || || || || ||SG | ||
| || | | || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Plasmacytoma||Disease|| || || || || | |Plasmacytoma||Disease|| || || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga) | ||
|SG | |||
| || | | || | ||
| | |NEW (No Prior) - no content on version 4 page "Plasmacytoma' originally assigned to Zhenya Tang | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Plasma cell myeloma / multiple myeloma||Disease|| || || || || ||SG | |Plasma cell myeloma / multiple myeloma||Disease|| || || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG | ||
| || | | || | ||
| | |(1) Plasma Cell Myeloma + (2) Plasma Cell Myeloma Variants | ||
| | |(1) Huan Mo, MD, MS and Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas + (2) Fariborz Rashid-Kolvear, PhD, FACMG, FCCMG | ||
| | |Pending | ||
| | | | ||
| | | | ||